{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:22:07Z","timestamp":1779416527246,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clnesp.2026.103135","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:25:32Z","timestamp":1774052732000},"page":"103135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum creatinine-to-cystatin C ratio at dialysis initiation predicts all-cause mortality: A retrospective cohort study"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7182-9003","authenticated-orcid":false,"given":"Motoki","family":"Ambe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Sunohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Tayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.103135_bib1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/jama.2024.16338","article-title":"Dialysis for chronic kidney failure: a review","volume":"332","author":"Flythe","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.clnesp.2026.103135_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1744-9987.12378","article-title":"An overview of regular dialysis treatment in Japan (As of 31 December 2013)","volume":"19","author":"Masakane","year":"2015","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.clnesp.2026.103135_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10157-021-02163-z","article-title":"Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deaths","volume":"26","author":"Kubo","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5551\/jat.49833","article-title":"The incidence and associated factors of sudden death in patients on hemodialysis: 10-year outcome of the Q-Cohort study","volume":"27","author":"Hiyamuta","year":"2020","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.clnesp.2026.103135_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12882-020-02026-x","article-title":"Risk factors for mortality in elderly haemodialysis patients: a systematic review and meta-analysis","volume":"21","author":"Song","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2215\/CJN.10261013","article-title":"Comparative associations of muscle mass and muscle strength with mortality in dialysis patients","volume":"9","author":"Isoyama","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/10408360490504934","article-title":"Biochemistry and clinical role of human cystatin C","volume":"41","author":"Mussap","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.clnesp.2026.103135_bib8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/0006-291X(89)90818-8","article-title":"The human cystatin C gene (CST3) is a member of the cystatin gene family which is localized on chromosome 20","volume":"162","author":"Saitoh","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clnesp.2026.103135_bib9","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1038\/s41598-020-61383-7","article-title":"Association between cystatin C gene polymorphism and the prevalence of white matter lesion in elderly healthy subjects","volume":"10","author":"Maniwa","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2026.103135_bib10","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1161\/STROKEAHA.107.513648","article-title":"Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms","volume":"39","author":"Aoki","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.clnesp.2026.103135_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.0000117180.57731.36","article-title":"Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease","volume":"24","author":"Eriksson","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clnesp.2026.103135_bib12","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.21037\/jtd.2016.03.62","article-title":"Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients","volume":"8","author":"Thongprayoon","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.clnesp.2026.103135_bib13","first-page":"47","article-title":"Cystatin C--a paradigm of evidence based laboratory medicine","volume":"29","author":"Chew","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.clnesp.2026.103135_bib14","article-title":"Serum creatinine\/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults","volume":"10","author":"Tan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2026.103135_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17987\/jcsm-cr.v3i1.57","article-title":"Relationship between sarcopenia and the serum creatinine\/cystatin C ratio in Japanese rural community-dwelling older adults","volume":"3","author":"Kusunoki","year":"2018","journal-title":"JCSM Clin Rep"},{"key":"10.1016\/j.clnesp.2026.103135_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2018.02.025","article-title":"Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes","volume":"139","author":"Osaka","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnesp.2026.103135_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11255-018-2015-6","article-title":"The creatinine\/cystatin C ratio provides effective evaluation of muscle mass in kidney transplant recipients","volume":"51","author":"Yanishi","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.23876\/j.krcp.21.214","article-title":"Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease","volume":"41","author":"An","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.clnesp.2026.103135_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/2175-8239-jbn-2020-0092","article-title":"Association between severe chronic kidney disease defined by cystatin-c and creatinine and clinical outcomes in an elderly population - an observational study","volume":"43","author":"Tavares","year":"2021","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.810901","article-title":"Changes in mortality according to creatinine\/cystatin C ratio in chronic kidney disease and non-chronic kidney disease patients","volume":"9","author":"Hwang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.clnesp.2026.103135_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.996674","article-title":"Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease","volume":"9","author":"Hyun","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2026.103135_bib22","article-title":"Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2026.103135_bib23","article-title":"Predictive value of creatinine-cystatin C ratio for mortality and technique failure in anuric peritoneal dialysis patients","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren Fail"},{"key":"10.1016\/j.clnesp.2026.103135_bib24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.jrn.2025.01.005","article-title":"Combination of clinical frailty score and myostatin concentrations as mortality predictor in hemodialysis patients","volume":"35","author":"Cornet","year":"2025","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.clnesp.2026.103135_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/j.ajkd.2014.08.010","article-title":"The kinetics of cystatin C removal by hemodialysis","volume":"65","author":"Huang","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clnesp.2026.103135_bib26","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1046\/j.1523-1755.2000.07606.x","article-title":"The removal of uremic toxins","volume":"76","author":"Dhondt","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clnesp.2026.103135_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1523-1755.2002.00216.x","article-title":"Middle molecule and small protein removal in children on peritoneal dialysis","volume":"61","author":"Montini","year":"2002","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.clnesp.2026.103135_bib28","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/clinchem\/44.12.2556","article-title":"Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression","volume":"44","author":"Kos","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.clnesp.2026.103135_bib29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clnesp.2026.103135_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","article-title":"Collaborators developing the Japanese equation for estimated GFR. GFR estimation using standardized serum cystatin C in Japan","volume":"61","author":"Horio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clnesp.2026.103135_bib31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1515\/CCLM.2007.504","article-title":"Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population","volume":"45","author":"Ichihara","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clnesp.2026.103135_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clnesp.2026.103135_bib33","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s10157-011-0525-y","article-title":"Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance","volume":"15","author":"Horio","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10157-021-02050-7","article-title":"Ratio of serum creatinine to cystatin C is related to leg strength in predialysis CKD patients","volume":"25","author":"Shiomi","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnesp.2026.103135_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Writing group for the European working group on sarcopenia in older people 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2026.103135_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41100-019-0209-8","article-title":"Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases","volume":"5","author":"Yamagata","year":"2019","journal-title":"Ren Replace Ther"},{"key":"10.1016\/j.clnesp.2026.103135_bib38","article-title":"Effect of nutritional intervention combined with resistance exercise on clinical indicators of patients with sarcopenia in maintenance hemodialysis: a systematic review and meta-analysis","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren Fail"},{"key":"10.1016\/j.clnesp.2026.103135_bib39","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s11255-021-02799-6","article-title":"Effects of pre-dialysis resistance training on sarcopenia, inflammatory profile, and anemia biomarkers in older community-dwelling patients with chronic kidney disease: a randomized controlled trial","volume":"53","author":"Gadelha","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.clnesp.2026.103135_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s41100-024-00585-5","article-title":"Annual dialysis data report 2021, Japanese Society for Dialysis Therapy (JSDT) renal data registry","volume":"10","author":"Hanafusa","year":"2024","journal-title":"Ren Replace Ther"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726002317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726002317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:28:42Z","timestamp":1779413322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726002317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S2405457726002317"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103135","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum creatinine-to-cystatin C ratio at dialysis initiation predicts all-cause mortality: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103135"}}